|
|
KEPPRA 100MG/ML SYRUP (GSK/COL) LEVETIRACETAM
|
|
|
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
Epilepsy .
|
|
|
Somnolence, weakness, and dizziness, depression, nervousness.
|
|
|
Adult: Monotherapy: 500mg daily increased by 500mg increments every 2 weeks. Maximum dose 3g daily in divided doses. Adjunct therapy: 1g on first day of treatment, increased by 1g increments every 2-4 weeks. Maximum dose 3g daily in divided doses. Chil
|
|
|
|
|
|
|
|
|
|
|
|
|